LhARA is a Laser hybrid Accelerator for Radiobiological Applications in which laser interactions drive the creation of a large flux of protons or light ions.

LhARA is a Laser hybrid Accelerator for Radiobiological Applications in which laser interactions drive the creation of a large flux of protons or light ions.
Novel lipid nanoparticles (LNPs) for targeted delivery of RNA-based vaccines and therapeutics, with improved long-term (12 months) thermostability at ambient temperatures (as high as 40 °C), in aqueous liquid or lyophilised form.
Novel heme oxygenase 1 (HO-1) probe compositions, and methods covering easy-to-use and rapid readouts of cell protection in cardiovascular diseases, hemorrhage and red cell disorders.
novel oligonucleotides that bind to H19, displacing Let-7 miRNAs, leading to a reduction in inflammation in muscle tissues, and consequently a reduction in muscle wasting.
A novel growth medium for the culture of Lactobacillus iners to unprecedented high cell densities within 24 hours.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean nec venenatis arcu. In fermentum non tellus nec vulputate. Integer accumsan, nunc sit amet porta commodo, diam sapien feugiat purus, at imperdiet arcu nisi quis dui. Etiam vel nisl sem. Proin felis nisl, fringilla eu eros ac, sodales pellentesque sem.